
    
      In this prospective, non-randomized, observer-blind observational study, up to 200 patients
      who meet the study's eligibility criteria will be enrolled at up to 20 study centers.
      Enrollment will be actively managed by the sponsor.

      Blood samples will be collected up to 14 days before transplantation, and then at 2-week
      intervals for the 6 months after the transplant procedure.

      Study duration: 15 months: 9 months to enroll all patients, with 6 months (182 days) of
      participation for each patient.
    
  